Animal Medication

Animal Medication

Global Animal Medication Market to Reach US$45.9 Billion by 2030

The global market for Animal Medication estimated at US$33.5 Billion in the year 2023, is expected to reach US$45.9 Billion by 2030, growing at a CAGR of 4.6% over the analysis period 2023-2030. Companion Animals Medication, one of the segments analyzed in the report, is expected to record a 4.8% CAGR and reach US$20.7 Billion by the end of the analysis period. Growth in the Cattle Farm Animals Medication segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$9.1 Billion While China is Forecast to Grow at 7.7% CAGR

The Animal Medication market in the U.S. is estimated at US$9.1 Billion in the year 2023. China, the world`s second largest economy, is forecast to reach a projected market size of US$9.8 Billion by the year 2030 trailing a CAGR of 7.7% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 3.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.0% CAGR.

Global Animal Medication Market - Key Trends and Drivers Summarized

Veterinary medicine is an essential field that extends far beyond the care of animals, touching on broader aspects of public health, food safety, and environmental protection. Veterinarians play a crucial role in the health management of both domestic and wild animals, performing a variety of tasks from routine examinations and vaccinations to more complex surgical procedures. The scope of veterinary medicine also encompasses significant public policy issues, emphasizing the veterinarians` unique qualification as doctors trained to protect the health of both animals and humans. Their expertise is crucial in managing the health of diverse animal species, tackling environmental challenges, and ensuring food safety through the control of zoonotic diseases, which are infectious diseases that can be transmitted from animals to humans.

The field of veterinary medicine significantly contributes to biomedical research, particularly in the development of new treatments and cures for diseases affecting both humans and animals. Veterinarians work collaboratively with scientists in various disciplines to advance medical science, ensuring ethical and effective use of animals in research and adhering to stringent regulatory standards. This interdisciplinary approach helps in the discovery of lifesaving therapies, underpinning the critical role of veterinary medicine in enhancing health across species. Moreover, veterinarians are instrumental in managing public health risks related to zoonotic diseases and bioterrorism, making their role indispensable in national security and disease outbreak prevention.

The global practice of veterinary medicine is influenced by several growth drivers, including advancements in veterinary diagnostics, which enhance the precision of treatments and the demand for advanced animal medications. Increased pet ownership and the humanization of pets have raised the standards of pet healthcare, mirroring human medical care practices and boosting the demand for specialized animal medications. Furthermore, the expansion of telemedicine in veterinary practices offers convenient access to health consultations and prescriptions, increasing the use of animal medications. Regulatory changes aimed at improving animal health standards are driving the development of compliant pharmaceutical offerings, while the growth in livestock production necessitates robust health management systems to maintain productivity. Additionally, the rising prevalence of zoonotic diseases has heightened the importance of effective animal health management strategies to prevent such diseases, promoting public health and safety. Collectively, these factors underscore the dynamic and evolving landscape of veterinary medicine, highlighting its increasing complexity and the growing recognition of its impact on broader health and environmental issues.

Select Competitors (Total 63 Featured) -

• Bayer AG
• Boehringer Ingelheim International GmbH
• Ceva Santé Animale S.A.
• Dechra Pharmaceuticals Plc.
• Eli Lilly and Company
• Merck Animal Health
• Vetericyn Inc.
• Vétoquinol SA
• Virbac SA
• Zoetis Inc.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.